Case Report: Baricitinib as an Alternative in the Maintenance Therapy for Macrophage Activation Syndrome Secondary to Nodular Panniculitis

BACKGROUND: Macrophage activation syndrome (MAS) is a severe complication of autoimmune diseases with high mortality. We report the effectiveness of baricitinib as an option for the maintenance therapy in MAS secondary to nodular panniculitis. CASE SUMMARY: A 24-year-old female came to our hospital...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Guanqun, Huang, Zhengping, Huang, Zhixiang, Wang, Yunqing, Deng, Weiming, Zheng, Shaoling, Li, Tianwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298961/
https://www.ncbi.nlm.nih.gov/pubmed/35874753
http://dx.doi.org/10.3389/fimmu.2022.914265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298961/
https://www.ncbi.nlm.nih.gov/pubmed/35874753
http://dx.doi.org/10.3389/fimmu.2022.914265

Ejemplares similares